- Home
- MCR vs NMRA Comparison
MCR vs NMRA Comparison
Compare MCR & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- NMRA
- Stock Information
- Founded
- MCR 1989
- NMRA 2019
- Country
- MCR United States
- NMRA United States
- Employees
- MCR N/A
- NMRA N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- NMRA
- Sector
- MCR Finance
- NMRA
- Exchange
- MCR Nasdaq
- NMRA Nasdaq
- Market Cap
- MCR 265.5M
- NMRA 268.5M
- IPO Year
- MCR N/A
- NMRA 2023
- Fundamental
- Price
- MCR $6.42
- NMRA $1.85
- Analyst Decision
- MCR
- NMRA Hold
- Analyst Count
- MCR 0
- NMRA 8
- Target Price
- MCR N/A
- NMRA $5.83
- AVG Volume (30 Days)
- MCR 66.7K
- NMRA 489.7K
- Earning Date
- MCR 01-01-0001
- NMRA 11-11-2025
- Dividend Yield
- MCR 8.52%
- NMRA N/A
- EPS Growth
- MCR N/A
- NMRA N/A
- EPS
- MCR 0.38
- NMRA N/A
- Revenue
- MCR N/A
- NMRA N/A
- Revenue This Year
- MCR N/A
- NMRA N/A
- Revenue Next Year
- MCR N/A
- NMRA N/A
- P/E Ratio
- MCR $16.61
- NMRA N/A
- Revenue Growth
- MCR N/A
- NMRA N/A
- 52 Week Low
- MCR $5.63
- NMRA $0.61
- 52 Week High
- MCR $6.70
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- MCR 50.40
- NMRA 57.48
- Support Level
- MCR $6.36
- NMRA $1.70
- Resistance Level
- MCR $6.50
- NMRA $1.93
- Average True Range (ATR)
- MCR 0.07
- NMRA 0.13
- MACD
- MCR -0.01
- NMRA 0.01
- Stochastic Oscillator
- MCR 40.11
- NMRA 81.13
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.